|
HS Code |
236842 |
| Chemical Name | Secobarbital Sodium Salt |
| Molecular Formula | C12H17N2NaO3 |
| Molecular Weight | 260.27 g/mol |
| Cas Number | 260-39-3 |
| Appearance | White crystalline powder |
| Solubility In Water | Very soluble |
| Storage Temperature | 2-8°C |
| Melting Point | 165-170°C (decomposes) |
| Synonyms | Sodium secobarbital, Seconal Sodium |
| Route Of Administration | Oral, Intravenous |
| Usage | Short-term treatment of insomnia, preoperative sedation |
As an accredited Secobarbital Sodium Salt factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Secobarbital Sodium Salt, 5 grams, is supplied in a sealed, amber glass vial with a tamper-evident screw cap and labeled for research use. |
| Shipping | Secobarbital Sodium Salt is shipped in tightly sealed containers, protected from light and moisture, and labeled with hazardous material tags per regulatory guidelines. Shipping complies with all local and international chemical transport regulations, including temperature control if required, and handling by authorized personnel. Safety Data Sheets accompany each shipment for reference. |
| Storage | Secobarbital Sodium Salt should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, well-ventilated area, away from incompatible substances such as strong oxidizers and acids. Store at room temperature, typically between 15–25°C (59–77°F). Ensure proper labeling and access control to prevent unauthorized use or accidental exposure. |
Applications of Secobarbital Sodium Salt in Industrial ManufacturingSecobarbital sodium salt serves as a specialized active pharmaceutical ingredient and chemical intermediate due to its pharmacological properties and regulated status. Our facility supplies this compound in line with stringent quality protocols for licensed downstream industries, focusing on high-purity batches that support production stability and end-use safety. Below, we detail the principal industrial applications where compliance, formulation, and processing differ by sector. 1. Active Pharmaceutical Ingredient Production for Hypnotic MedicationsPharmaceutical manufacturers incorporate secobarbital sodium salt as a controlled active compound in prescription hypnotics for short-term management of insomnia and sedation. Material processing requires exact granulation and blending, carried out under validated conditions to ensure compliance with pharmacopeial monographs. Facility QA/QC teams monitor API input and process flow to match each authorized drug dossier, ensuring batch traceability and uniform potency in finished tablets or capsules. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Bulk Compound Formulation for Hospital Pharmacy CompoundingLicensed hospital compounding facilities utilize secobarbital sodium salt to prepare short-stability individualized sedation and pre-operative medications, especially when commercial drug forms are unavailable. Dedicated compounding zones maintain strict environmental monitoring to prevent cross-contamination. Pharmacists weigh and dissolve the salt in sterile aqueous vehicles according to each patient-specific prescription, ensuring traceability against controlled drug logs and local compounding guidelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Reference Standard Preparation for Analytical LaboratoriesCertified analytical laboratories employ secobarbital sodium salt as a reference standard for calibration of chromatographic and spectrophotometric equipment in clinical and forensic toxicology. Technicians prepare high-purity calibration curves and matrix-matched controls under ISO 17025 accreditation. Each standard is weighed with analytical balances and dissolved in certified solvents with strict documentation to ensure traceability back to the manufacturer lot. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Preclinical Research Compound Supply for Regulated StudiesContract research organizations and preclinical facilities source secobarbital sodium salt to investigate central nervous system effects and pharmacokinetics in regulated animal models. All transfers follow controlled substance protocols, with material weighed and formulated under GLP-compliant procedures. Research staff suspend the compound in pharmaceutical grade carriers for oral gavage or injection, taking detailed logs for dose preparation, residuals, and animal usage. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Secobarbital Sodium Salt prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Secobarbital Sodium Salt stands as a specialty pharmaceutical compound we have produced steadily for decades. Having developed and scaled large-batch synthesis of secobarbital sodium since regulatory controls intensified worldwide, our team has gained a close familiarity with sourcing, handling, and quality requirements that matter daily, rather than what appears on a typical catalog page. Individuals working in health sciences understand the precision required in controlled substances—there’s no wiggle room. We manufacture secobarbital sodium to meet strict purity standards because both researchers and pharmacists look for consistent results, and the risks of inconsistency in this sector never fade away.
Barbiturates have experienced fluctuating reputations over the years, yet certain medical situations still call for their use. Secobarbital sodium continues to show up in clinical contexts for short-term insomnia, refractory epilepsy, or specified anesthetic regimens. No matter the regulatory climate, the science hasn’t changed: the therapeutic window is narrow, metabolism varies patient by patient, and impurities or unpredictable dissolution throw off that slim margin of safety. We follow validated synthesis paths built on industry-proven methods and our own learnings from process refinement. No one approaches large-scale barbiturate production casually; oversight by both regulators and our internal QC teams demands a batch-to-batch repeatability. Our instructions for lot validation follow current pharmacopoeia specifications, and every single batch receives full HPLC and titration analysis—methods refined by on-the-floor chemists who solve the quirks uncovered by continuous real-world work.
Secobarbital sodium salt can only be made by teams with deep chemical engineering experience. Small-scale outsourced operations tend to introduce risks common in generic powder trading: variable particle size, suspect provenance of starting materials, and inconsistent moisture content that can alter dissolution in formulation. In contrast, our lines operate under controlled environments, where all solvents and intermediates fit pharmacopeia-grade standards. Scale-up economics demand that we optimize at every step, but our clients—research groups, hospitals, and authorized compounding facilities—always notice the difference in purity, particle size, and stability between our product and material sourced via indirect channels.
There’s a reason our chemists keep detailed notes for every run. The sodium salt form of secobarbital stabilizes the active barbiturate for compounded oral and parenteral preparations. Water solubility for the sodium salt enables precise dosing, which allows compounding pharmacists to prepare solutions with predictable strength. We set acceptance criteria for color, appearance, and melting point above pharmacopoeial minimums, because real-world use often uncovers subtleties that a certificate of analysis alone can’t predict. Our particle-size measurements let us guarantee quick and even dissolving properties, which matters for both clinical compounding and assay reproducibility in analytical work.
We watch for trace residual solvents more strictly than standard limits require, since some customers run stability studies over a range of injection vehicles—traces that may not matter in a dry powder can cause long-term storage issues or reactivity. The same attention goes into elemental analysis, since heavy metals or catalyst remnants, even well below official thresholds, may have implications for highly sensitive biological studies or international shipments. Most customers expect pharmacopoeia compliance—few get to see the behind-the-scenes work we do to keep performance consistent, even when ingredient shortages or regulatory changes threaten upstream supply.
In the clinical world, secobarbital sodium sees limited but enduring demand. Hospitals rely on it as a short-acting hypnotic, particularly for preoperative sedation and specific epilepsy emergencies. Researchers continue to probe barbiturate receptor pharmacology, CNS models, and toxicology using secobarbital sodium in controlled lab studies. Every one of these scenarios relies on confidence in the underlying chemistry—an unstable product or a deviation in crystallinity can throw off not only dosing but entire research projects.
Research and development groups tackle complex analyses that need a reliable gold standard. Our own experience with custom batch requests stems from collaborating on method validation: reference standards must match main product characteristics—no shortcuts. Multiple national health systems require deeply documented lot histories for every kilogram. From small vials for preclinical trials to multi-kilo lots for hospital compounding pharmacies, we keep tracking records and full origin traceability. That standard did not arrive overnight; it has grown out of dozens of inspections, audits, and corrective action cycles.
The landscape for barbiturates changes with every few years. Regulatory authorities move quickly to review everything from manufacturing licenses to packaging and transport. We keep our lines ready for unscheduled audits and track electronic batch records, starting material certificates, and ongoing stability results—this ensures the data flow remains transparent from synthesis to delivery. Compliance with national and international precursor chemical regulations forms the backbone of our product’s legal supply status; the legal risks of supply chain missteps in this sector get no sympathy from authorities.
The chain of custody matters most for controlled substances. We build product traceability into our own IT systems, linking batch codes directly to every outgoing shipment and often share raw data with institutional clients before shipments leave the dock. This builds the trust required for clinical trial supply or high-scrutiny government RFPs. Emergency medicine teams count on our product’s instant solubility and consistency, but so do state-approved palliative care organizations seeking predictable results for those in their final days.
Factory work shapes the product as much as technical documents do. Our synthesis reactors, drying chambers, and grinders see daily attention—not just for calibrated output but to catch early warning signs: color shifts, sudden humidity spikes, nonstandard crystal growth. The operators running evening shifts have flagged more nascent issues than any automated monitor. Experience teaches the fine points no standard operating procedure can cover—knowing how the product looks and behaves at each stage, how it feels under a spatula, and how scent should barely change between lots.
Every manufacturer claims adherence to quality control, yet in this field, the margin for error shrinks further every year. We revisit every SOP on a rolling basis, revising cleaning protocols and worker training modules as issues surface. Team members bring the lessons of failed batches to the discussion table; protecting product quality isn't an academic exercise, it's a real-world priority. An early morning phone call from a compounding pharmacist troubleshooting reconstitution issues will trigger a review of flow chart steps—did we change instruments, source starting material from a new partner, or move staff too quickly through drying? These daily interactions with real users inform improvements that reach back into our process lines.
Those familiar with pharmaceutical chemistry know that not all barbiturates behave the same way. Secobarbital sodium’s key advantage comes from its rapid onset and shorter duration of action compared to longer-acting cousins like phenobarbital sodium. In specialized medical settings, this means practitioners can employ it for procedures requiring predictable, short-term effects rather than sustained sedation. The pharmacokinetic profile of secobarbital sodium plays a crucial role in clinical decision-making; both its onset and metabolism pattern differ from amobarbital sodium or pentobarbital sodium.
Each barbiturate possesses unique solubility, onset time, and potency. We play close attention to these differences during both process control and customer guidance. For example, our secobarbital sodium batches dissolve more swiftly in water than phenobarbital sodium, which supports its applications in acute care and research. Amobarbital sodium’s slightly higher lipid solubility translates into a different patient response and alternative clinical uses. From a manufacturing standpoint, secobarbital sodium’s synthesis also poses more stringent control challenges compared to some related substances, adding to the care and oversight required.
Most researchers and clinicians have seen firsthand that switching sources for the same nominal ingredient can introduce unpredictable clinical or analytical results. Many practitioners report that the smallest inconsistencies—tiny particle size outliers, unexpected color hue, or slower solution clarity—can affect dose accuracy. Our response draws from years of running down these root causes: we discuss environmental controls, cross-check with our historical process records, and often run supplemental testing to resolve anomalies. No formulation technology can fully mask low-quality starting material; we invest more in precise grinding, moisture regulation, and thorough batch-blending than generic powder producers.
Shipping secobarbital sodium requires more than meeting technical data sheet criteria. Secure packaging, temperature monitoring, and complete customs paperwork all flow directly out of our familiarity with cross-border logistics under regulatory scrutiny. Our logistics team coordinates directly with destination officials, addressing specific import permits and documentation needed for every order. Delays or rejections sometimes result from the smallest mismatch in labeling or language; years of practice handling these situations means our paperwork reflects not only the law, but practical know-how for each jurisdiction.
We keep careful logs of every shipment—destination, carrier, chain of custody, and even vehicle temperature readings when necessary. Opening up our facility to inspection by national medicines agencies has reinforced our commitment to full transparency in packing, warehousing, and shipping practices. That means no skipped steps: from double-sealed primary containers to tamper-evident outer boxes, we prevent diversion and degradation across routes that can span multiple continents. We work closely with in-house compliance experts, learning from each export hiccup, and revising packaging formats or container labels as required by new guidelines.
The field of medicinal chemistry never stands still. Investment in reactor automation, real-time in situ monitoring, and advanced impurity profiling has changed the way we manufacture secobarbital sodium. These tools let us detect process drift early, stabilize product specifications, and generate data for both in-house and customer review. A decade ago, even basic production lines lacked live tracking; today, we can intervene in real time to adjust reaction parameters before deviation results in wasted product or failed quality controls.
Our analytical division employs the latest techniques for impurity profiling: ion chromatography, LC-MS, and advanced thermal analysis. These approaches allow quick detection of subtle changes others might miss, letting us intervene swiftly in the rare case that a run veers outside specification. Clients seeking regulatory submissions often request expanded impurity panels, extended stability data, or side-by-side comparisons with international standards. Responding requires not only technical capability, but a willingness to share what we learn. In some cases, we’ve partnered with academic researchers exploring new analytical workflows, bringing real production data to bear on tough challenges like trace impurity analysis or long-term storage studies.
The barbiturate sector today is defined as much by global compliance as by chemistry. Over years of manufacturing, we have realized that trust builds through honest feedback, fast response to quality concerns, and willingness to adapt as science and regulation evolve. Lessons often hit hardest when an unexpected equipment failure stops a line, a client detects a minor deviation before we do, or supply chains tighten without warning. We treat these moments as learning experiences. Our continuous improvement loop links every insight from the line or the customer to consistent upgrades in process, training, or validation.
Finished product alone doesn’t illustrate the full story; it takes hundreds of decisions, shared insights, and careful vigilance from a multi-disciplinary team to keep a controlled substance like secobarbital sodium at its quality peak. This means close partnerships across chemistry, engineering, compliance, distribution, and customer service teams. New protocols, sourced from lessons learned on the ground, roll out to the entire team, instilling both accountability and pride in work that never gets easier.
Barbiturate manufacturing faces continuous challenges. Regulatory controls change rapidly, with authorities expecting updated procedures, advanced documentation, and new data formats with little notice. Sourcing challenges for high-purity starting materials become more acute each time permitted suppliers shift. Maintaining predictable, safe, and effective secobarbital sodium supplies requires continuous vigilance—sometimes, it means requalifying vendors or redesigning storage areas to meet revised climate control standards. We monitor research literature and regulatory bulletins closely, updating protocols the moment revised impurity thresholds appear or new contaminants emerge globally.
Team education forms a key part of our continuing reliability. Regular workshops and audits go beyond mere compliance—they surface frontline concerns from operators and supervisors who work with secobarbital sodium each day. Our training encourages every worker to call out even small changes in process or material—this feedback is critical to identifying batch variations and heading off potential problems before they reach the customer. Facility upgrades, method revalidations, and process automation investments all flow from our commitment to solve real-world issues, not just tick boxes for a file.
Looking across all the stories, setbacks, and improvements we’ve seen, reliability doesn’t stem from a document or a machine. It grows out of people catching problems early, maintaining open lines of communication with every researcher, hospital pharmacist, or regulatory reviewer who depends on what we produce. No matter how digital our workflow becomes, the hands-on care that goes into every kilogram of secobarbital sodium cannot be replaced. Whether supporting clinical research, ensuring uninterrupted care in urgent medical settings, or helping academic groups break new scientific ground, our approach remains deeply human—measured by outcomes, proven by consistent performance, and refined by decades at the bench.
Every gram we ship owes its reliability to the diligence of the entire team—from senior chemists setting process controls to warehouse staff monitoring every package out the door. From cleaning schedules to emergency preparedness, and from cross-checking supplier documentation to reworking a dry room on a few hours’ notice, we take every step needed to guarantee product quality and safety. In a world where fine margins separate reliable medicine from unacceptable risk, attention to detail matters more with secobarbital sodium than with almost any other bulk pharmaceutical ingredient we make.